Campbell & Co Investment Adviser’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-52,522
Closed -$2.13M 1124
2025
Q4
$2.13M Buy
+52,522
New +$2.28M 0.1% 311
2025
Q3
Sell
-10,106
Closed -$526K 1143
2025
Q2
$526K Buy
+10,106
New +$555K 0.03% 768
2024
Q4
Sell
-3,039
Closed -$219K 1098
2024
Q3
$219K Sell
3,039
-679
-18% -$47.9K 0.02% 1002
2024
Q2
$258K Sell
3,718
-12,719
-77% -$928K 0.02% 889
2024
Q1
$1.32M Buy
16,437
+9,609
+141% +$856K 0.11% 284
2023
Q4
$748K Sell
6,828
-14,644
-68% -$1.51M 0.07% 523
2023
Q3
$2.17M Buy
+21,472
New +$2.47M 0.26% 74
2023
Q1
Sell
-3,206
Closed -$284K 839
2022
Q4
$284K Sell
3,206
-12,085
-79% -$1M 0.07% 575
2022
Q3
$1.23M Buy
+15,291
New +$1.44M 0.28% 83
2020
Q1
Sell
-16,354
Closed -$1.83M 120
2019
Q4
$1.83M Buy
+16,354
New +$1.74M 0.56% 14
2018
Q4
Sell
-3,156
Closed -$250K 361
2018
Q3
$250K Hold
3,156
0.17% 279
2018
Q2
$231K Sell
3,156
-2,206
-41% -$150K 0.18% 267
2018
Q1
$340K Buy
+5,362
New +$320K 0.29% 130

Other funds holding CNMD

Campbell & Co Investment Adviser's CNMD Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of CONMED (CNMD) in Q1 2026, closing a stake of 52,522 shares — an estimated $2.13M sold.

Campbell & Co Investment Adviser first reported a position in CNMD in Q1 2018 and held it in 13 quarters. The position peaked at $2.17M in Q3 2023. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.

  • Campbell & Co Investment Adviser reported no remaining CONMED position as of Q1 2026 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 52,522 CONMED shares in Q1 2026, an estimated $2.13M.
  • Campbell & Co Investment Adviser first reported a position in CONMED in Q1 2018 and held it in 13 quarters.
  • Campbell & Co Investment Adviser's CONMED position peaked at $2.17M in Q3 2023.
  • 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.